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Leverage of an Existing Cervical Cancer
Prevention Service Platform to Initiate
Breast Cancer Control Services in
Zambia: Experiences and Early Outcomes
abstract
Purpose In 2005, the Cervical Cancer Prevention Program in Zambia (CCPPZ) was implemented and has
since provided cervical cancer screen-and-treat services tomore than 500,000women. By leveraging the
successes andexperiences of theCCPPZ,we intended to build capacity for the early detection and surgical
treatment of breast cancer.
Methods Our initiative sought to build capacity for breast cancer care through the (1) formation of a breast
cancer advocacy alliance to raise awareness, (2) creation of resource-appropriate breast cancer care
training curricula for mid- and high-level providers, and (3) implementation of early detection and
treatment capacity within two major health care facilities.
Results Six months after the completion of the initiative, the following outcomes were documented: Breast
health education and clinical breast examination (CBE) services were successfully integrated into the
service platforms of four CCPPZ clinics. Two new breast diagnostic centers were opened, which provided
access to breast ultrasound, ultrasound-guided core needle biopsy, and needle aspiration. Breast health
education and CBE were provided to 1,955 clients, 167 of whom were evaluated at the two diagnostic
centers; 55 of those evaluated underwent core-needle biopsy, of which 17 were diagnosed with invasive
cancer. Newly trained surgeons performed six sentinel lymph node mappings, eight sentinel lymph node
dissections, and 10 breast conservation surgeries (lumpectomies).
Conclusion This initiative successfully established clinical services in Zambia that are critical for the early
detection and surgical management of breast cancer.
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INTRODUCTION
Breast cancer in sub-Saharan Africa is charac-
terized by low but rapidly increasing disease
incidence,1,2 late-stage presentation, highmortal-
ity, andaheavyburdenamongyoungerwomen.3,4
Increasing longevity and the replacement of tra-
ditional African lifestyles with Western patterns of
food consumption, childbearing, and breastfeed-
ing undergird the increase in disease incidence.2
Much of the late-stage presentation and high
mortality rates can be attributed to system-level
barriers to early detection and treatment.5 Other
contributing factors include lack of awareness of
early signs and symptoms of the disease6,7; a gen-
eral belief that cancer has a supernatural origin
and is always fatal8; use of traditional therapies
before or in lieu of seeking modern treatment9-11;
andfearofspousalabandonmentaftermastectomy.12
The need for a high-impact, scalable, breast
cancer control model that has the inherent ca-
pability to adjust to the myriad of complex situations
and circumstances that women in low-resource
environments have to negotiate is paramount. In
this paper, we describe experiences and initial re-
sults of a public-private demonstration project to
expand access to breast cancer control services in
Zambia. It was built on the framework of a decade-
long program that successfully integrated cervical
cancer prevention interventions within service plat-
forms used to deliver HIV/AIDS care and treatment
in Zambia.
METHODS
Since 2005, the Zambian government, with sup-
port from the US President’s Emergency Plan













Author affiliations appear at
the end of this article.
Supported by the Susan G.
Komen Breast Cancer
















1 jgo.org JGO – Journal of Global Oncology
© 2017 by American Society of Clinical Oncology Licensed under the Creative Commons Attribution 4.0 License
Downloaded from ascopubs.org by University of North Carolina on May 18, 2021 from 152.002.176.242
Copyright © 2021 American Society of Clinical Oncology. See https://ascopubs.org/go/authors/open-access for reuse terms.
Centers for Disease Control Prevention, and in
partnership with local and US university-based
public health oncology experts and advocates,
has facilitated the implementation of a public-
sector cervical cancer prevention intervention—
Cervical Cancer Prevention Program in Zambia
(CCPPZ). Initially focused on the provision of
cervical cancer screening and treatment ser-
vices to HIV-infected women, it soon expanded
services to all women regardless of HIV status
as a result of patient demand. During the past
decade, albeit with resources disproportionate
to demand, cervical cancer prevention services
have been scaled nationally to 60 government-
operated public health clinics, at which more
than 500,000women have been screened since
program inception and 50,000 are screened
annually. An analysis of the first 100,000women
enrolled in the program revealed a screen-to-
detection ratio of 56 to 1 for high-grade cervical
precancer, an overall treatment rate of 70% for
women diagnosed with precancerous lesions,
and a shift in the percentage of early-stage in-
vasive cervical cancers from 20% to 42%.13 As
of February 2015, CCPPZ was officially inte-
grated into the government’s public health sys-
tem with an official desk—National Coordinator
of Cancer Prevention—now located at the Zam-
bian Ministry Health.
Our major objectives were to leverage the suc-
cesses and experiences of Zambia’s cervical
cancer prevention program and to use direct
participation at the point of care to build capac-
ity for detection and surgical treatment of breast
cancer in Zambia. We also assessed the clinical
advancements that resulted from the capacity-
building activities. The following cluster of
activities were conducted to implement the
initiative:
1. Creation of an alliance of advocacy groups:
With support from the Susan G. Komen
Foundation, the first step was to facilitate the
formation of an alliance of the five existing
breast andcervical cancer advocacygroups in
Zambia into a consortium—CAPRAZ (Cancer
Prevention Alliance Zambia)—with the fol-
lowing goals (1) intensify breast and cervical
cancer awareness campaigns in the com-
munity to dispel myths and misconceptions
surrounding the disease and its treatment; (2)
ensure that breast and cervical cancer health
promotion messages were evidence based
and contextually relevant, and (3) coordinate
and provide technical support for awareness
activities of member groups.
2. Assess capacity: After the organization of
CAPRAZ into a functional nonprofit organi-
zation, the next step was to assess breast
cancer early detection and diagnostic and
surgical treatment capacities. Toward this
end, breast oncology consultants from two
universitymedical centers in theUnitedStates
(University of Arkansas and University of
North Carolina, Chapel Hill) were invited to
Zambia to assess breast cancer care capacity
at the University Teaching Hospital in Lusaka
Province (the country’s single tertiary medical
facility that serves as its primary center for
postgraduate medical training) and Kabwe
General Hospital in Central Province (a large,
rural provincial medical center representative
of the types of health facilities that have been
prioritized by the Zambian National Cancer
Control Strategic Plan as high-priority sites for
the expansion of cancer control services).
Upon receipt of approval from relevant gov-
ernment agencies, the consultants visited the
two designated sites and worked daily along-
side local health professionals in their breast
clinics, surgical theaters, and postoperative
wards. They also attended hospital-based
educational conferences, convened meet-
ings with key academic stakeholders and
professional health care providers, gave
formal lectures on breast cancer diagnosis
and management to faculty and staff, and
hosted informal social gatherings. From
the assessment, it was determined that the
largest and most critical deficits in the
breast cancer care pathway at the two fa-
cilities were lack of capacity to perform the
following: (1)clinicalbreastexamination (CBEs),
(2) breast ultrasound, (3) ultrasound-guided
core needle biopsy of palpable breast masses,
and (4) conservative surgical treatment of breast
cancer. Other weaknesses and strengths are
listed in Table 1.
3. Curriculum development: The team of US
consultants, in partnershipwith Zambian health
care professionals, used information from the
assessment and knowledge of the local context
to develop a training curriculum aimed at
building capacity in these four areas. Once
developed, the curriculum was vetted by
senior members of the Zambian Ministry of
Health’s Technical Working Group for pur-
poses of modification and approval.
4. Implementation of the curriculum: Four months
after their initial visit, theUSoncologyconsultants
returned toZambiaand implemented the training
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curriculum (Table 2), in the form of a 1-week
long practicum at the University Teaching
Hospital, entitled “A Model for Expansion of
Breast Cancer Care in Zambia.” Training
consisted of a combination of didactics and
hands-onmentoring and evaluation by US in
the breast clinics and surgical theaters at
the University Teaching Hospital and Kabwe
General Hospital.
5. Development of benchmarks for evaluation:
The following benchmarks were established
for impact evaluation of the initiative:
(1) Cervical cancer screeningnursesworking
in government-operated primary health
centers could adequately deliver breast
health awareness education and CBE.
(2) Local radiographers (technicians) could
accurately perform ultrasonographic eval-
uation of palpable breast masses.
(3) General surgeons could safely and ef-
fectively perform ultrasound-guided core
needle biopsy and needle aspiration of
breast masses, axillary sentinel lymph
node (SLN) mapping with blue dye, SLN
dissection, and breast lumpectomy.
(4) Breast diagnostic centers would be
established at each of the two facilities
described as assessment sites, with the
capacity to performCBE, breast ultrasound,
and ultrasound-guided core needle biopsy
of palpable breast masses.
(5) Data collection platforms would be estab-
lished in each clinic.
(6) Referral pathways would be developed
between the breast diagnostic clinics and
either the departments of general surgery
at the respective hospitals or the national
cancer center (Cancer DiseasesHospital)
Table 1. Breast Cancer Early Detection and Surgical Capacity Assessment
Capacity Assessment
Weaknesses
No formally trained breast cancer surgeons and only one plastic surgeon available in the public sector
Underdeveloped oncologic surgical infrastructure at University Teaching Hospital: lack of well-equipped surgical intensive care unit; inadequate time
allotted for cancer cases in surgical theater; unreliable supply of blood products; shortage of anesthesiologists
Multidisciplinary approach to cancer management in its infancy
Small percentage of early-stage breast cancer cases on which to perform conservative therapy
One functional digital mammography machine in the public sector
Limited pathology capacity at Kabwe General Hospital
Only one radiation therapy facility in the country
Strengths
Well-established cervical cancer screening infrastructure available for use as a platform for clinic breast examination
General surgeons and radiographers at University Teaching Hospital and Kabwe General Hospital highly motivated to learn new skills
Directors of both hospitals supportive of improvement in breast cancer care at their respective facilities
Highly competent clinical oncologists and a national cancer center with capacity for radiation and chemotherapy
Ultrasound and ultrasound-guided biopsy equipment available at the University Teaching Hospital in Lusaka
Table 2. Breast Cancer Training Curriculum
Curriculum
Lectures
Clinical breast examination: methods, strengths, and weaknesses
Scanning techniques
Physics and principles
Normal breast ultrasound anatomy
Interpretation of sonographically detected focal breast lesions
Integration of breast ultrasound into surgical practice
Indications for fine-needle aspiration and core needle biopsy
Modern surgical management of breast cancer
Modern management of benign breast lesions
Breast cancer roundtable*




Ultrasound and ultrasound-guided biopsies of palpable breast masses
Surgical demonstrations in the general surgery theater at theUniversity TeachingHospital
Sentinel lymph node mapping using blue dye
Breast lumpectomy and sentinel lymph node biopsy
Modified radical mastectomy, axillary lymph node dissection, and bilateral
reconstruction (oncoplasty)
*Participants were cervical cancer prevention nurses, general surgeons, radiographers, oncologists,
nursing and medical students, and laboratory technicians.
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in Lusaka; referral pathwaysalsowouldbe
developed for chemotherapyand radiation
at the national cancer center in Lusaka.
(7) Educational activities implemented by
CAPRAZ in the catchment areas sur-
rounding the twohospitalswould increase
awareness of the signs and symptoms of
breast cancer andencouragewomenwith
breast concerns to seek care from local
health facilities.Member groups also would
begin to increase their participation in local
breast cancer initiatives, such as fund-
raisers, educational seminars, public lec-
tures, and awareness campaigns.
RESULTS
A 6-month evaluation of local activities by US
consultants revealed the following:
1. Four cervical cancer screening clinics at the
primary health care level—one in Kabwe and
three in Lusaka provinces—had successfully
integrated breast cancer education and CBE
into their routine service platforms.
2. Two new breast cancer diagnostic centers
were operational—one at Kabwe General
Hospital and the other at University Teaching
Hospital, and each provided CBE, breast ul-
trasound, ultrasound-guided core needle bi-
opsy, and needle aspiration.
3. A total of 1,955 women had undergone CBE
in the four primary health centers, of which
256 (13.1%) had palpable breast masses
(Table 3). All were referred to one of the two
new breast diagnostic centers for additional
evaluation; of these, 167 (65.2%) actually
attended. A secondary CBE at the referral
centers confirmed palpable breast masses in
59 (35.3%) of those who underwent the ex-
amination (Table 3).
4. Ultrasound-guided biopsies were indicated
andperformed in55of the59womenwhohad
confirmed palpable breast masses (Table 3).
Pathology results were available for 45 (81.8%)
of the 55 who underwent biopsy (Fig 1). Breast
cancer was confirmed in 17 (37.8%), and
benign breast lesions in 24 (43.6%). The
remaining four pathology results were clas-
sified as either normal or inadequate for di-
agnosis. The median (6 standard deviation)
age of women diagnosed with breast cancer
was 40 years (6 13.4 years). The median di-
ameter of breast cancer masses detected by
ultrasoundwas 2.9 cm. Fibroadenoma (n = 10)
was themost commonly reported benign lesion
(Table 4).
5. Six SLNmappings, eight SLNdissections, and
20 breast conservation surgeries (lumpecto-
mies) were performed independently by the
Zambian general surgeons. The histologic
margin status of lumpectomy surgical speci-
mens was not reported. No surgical compli-
cations were reported (Table 5).
DISCUSSION
Breast cancer is projected to increase in low- and
middle-income countries (LMICs) during the next
two decades. The vast majority of women who live
in these settings will die from their disease primar-
ily because of the advanced stage at which they
are diagnosed and lack of access to high-quality
treatment services. In addition, attempts to de-
velop effective breast cancer care service plat-
forms in such settings are made difficult by
widespread myths and misconceptions about the
disease as well as by competing health care prior-
ities. We took advantage of prior investments in the
integration of cervical cancer screening within HIV
services to launchanapproach tocapacity building
for the early detection and surgical treatment of
breast cancer in Zambia.
Cervical cancer screening nurses were trained
to provide breast cancer education and perform
CBE on appropriately aged asymptomatic and
symptomatic women who attended their clinics
for cervical cancer prevention services. Although
the most effective means for screening is mam-
mography,14 population-based mammographic
screening requires resources generally not widely
available in LMICs. In addition, its benefit-to-harm
ratio has been questioned recently, particularly in
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Fig 1. Breast biopsy
results (N = 55).
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that produces the majority of breast cancers in
LMICs.3,15 Although there is controversy about
the benefits of CBE,16-19 there is developing
evidence that it has the potential to downstage
disease. In an ongoing cluster-randomized trial
in India, CBE, when performed by community
health care workers, detected more (18.8 v
8.1 per 100,000 women) early-stage cancers
(stage I to IIA) in intervention versus control
villages.20
Two new diagnostic breast centers were estab-
lished and staffed with radiographers and general
surgeons who were trained in ultrasound and
ultrasound-guidedbiopsy, respectively.Ultrasound
is recommended as an appropriate tool for the
evaluation of women with palpable breast masses
in LMICs, given its relatively lowcost comparedwith
other imaging technologies, value as an adjunct to
CBE, and ability to support minimally invasive di-
agnostic procedures.21,22 Ultrasound, however, is
dependent on the quality and reliability of the
equipment and the experience of operators for
accuracy in the diagnosis of breast lesions.23When
usedeffectively, it candistinguish simplecysts from
solidmasses,provideanestimationof the likelihood
of malignancy, and be used to aid in biopsy for
pathologic diagnosis.24
Ultrasound-guided core needle biopsies are per-
formed todetermine theetiologyofpalpablebreast
masses and are indicated on the basis of the
sonographic characteristics of the mass, such
as shape, orientation, margin, echo pattern, pos-
terior acoustics, and boundary.25 Compared with
open incisional andexcisional biopsy, core-needle
biopsy is less invasive, less expensive, causes min-
imal scarring, and can be performed on an out-
patient basis.26 Core-needle biopsy also has the
benefit of provision of adequate tissue for determi-
nation of histologic grade; vascular and lymphatic
invasion; estrogen and progesterone receptor sta-
tuses;andthepresenceofmolecular tumormarkers,
such asHER2/neu.27 These prognostic variables
may help triage surgical interventions, such as
breast-conservation therapy,28 use of SLN bi-
opsy, or axillary lymph node dissection.27
Surgery is the cornerstone of breast cancer care
and is the most widely available therapy for breast
cancer in LMICs. Modified radical mastectomy
(MRM) is the most commonly performed surgi-
cal procedure for breast cancer in these settings,
largely as a result of late-stage presentation of
disease.Althoughgeneralsurgeons inZambiawere
well versed in performance of MRMs, their expo-
sure to breast conservation surgery (lumpectomy)
and axillary SLN mapping and dissection tech-
niqueswas limited.Thenumberof surgical theaters
was inadequate,andnotenough timewasallocated
to accommodate all of the surgical cases that had
been scheduled for surgical demonstrations by
visiting oncologists, which resulted in a less-than-
desired number for hands-on training. This ulti-
mately limited the training the surgeons received
in conservative surgery techniques. Because such
a large percentage of women presented with
advanced-stage disease, limited numbers of
Table 3. Breast Evaluation
Clinical Breast Examination Result
by Location No. (%) of Patients
Cervical cancer screening clinic (n = 4)
Clinical breast examination 1,955
Abnormal exam 256 (13.1)
Diagnostic breast clinic (n = 2)
Clinical breast examination 167
Abnormal exam 59 (35.3)
Diagnostic imaging performed 59 (100)
Diagnostic breast ultrasound (n = 59)
Ultrasound-guided core needle biopsy 55 (93.2)
Biopsy not indicated 4 (6.8)
Table 4. Breast Biopsy Results
Available Pathology* No. (%) of Patients†
Invasive carcinoma 17 (37.8)
Median tumor diameter by ultrasound,
mm
29
> 20 and < 50 7 (41.2)
> 50 3 (17.6)
Invasive ductal carcinoma 16 (94.1)
Invasive lobular carcinoma 1 (5.9)
Mean (SD) age at diagnosis, years 40 (13.4)
Benign breast disease 24 (53.3)
Fibroadenoma 10
Tubular adenoma 4
Fibrocystic breast changes 3
Mastitis 3
Breast abscess 1
Necrotizing tuberculosis granuloma 1
Giant cell reaction 1
Atypical ductal hyperplasia 1
Normal 2 (4.4)
Inadequate for histologic evaluation 2 (4.4)
*Available pathology reports = 45 of 55 total; 10 pathology reports were unavailable.
†Data reported are No. (%) of patients unless otherwise noted.
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early-stage breast cancer cases were available on
which to demonstrate breast lumpectomy and
SLN mapping/dissection. Despite these chal-
lenges, the surgeons were able to indepen-
dently perform breast conservation surgery
and SLN mapping and dissection techniques.
Breast conservation surgery for early-stage
disease is safe and has the same overall sur-
vival as mastectomy.29 It has the added benefit
of better cosmetic appearance, which is im-
portant, given the impact of cultural beliefs and
stigma on treatment-seeking behavior.12,30
MRMs, however, will remain the mainstay of
treatment of breast cancer in LMICs for the
foreseeable future given the limitations im-
posed by the lack of radiotherapy services
and inefficient resources for effective follow-
up programs.31 Complete level-1 and -2 axil-
lary dissections typically are performed during
breast cancer surgeries in LMICs because of
advanced-stage disease or the inability to per-
form less invasive axillary staging in early-stage
disease. With proper training, however, SLN
mapping and sampling can be performed,
which may increase the accuracy of axillary
staging in breast cancer and reduce morbid-
ity associated with complete axillary dissec-
tions.32 This will become a necessary skill as
more cancers are diagnosed at an early stage.
We used direct participation at the point of care
to inform the construction and implementation
of an approach to capacity building for the early
detection and surgical treatment of breast can-
cer in Zambia (Table 6). As an overall impact,
CBEs and breast education are now performed
by cervical cancer screening nurses at select
cervical cancer prevention clinics in Zambia.
Two new diagnostic breast centers have been
established that provide modern diagnostic
services in the form of breast ultrasound and
ultrasound-guided biopsies. Efforts are under-
way to make them sustainable by using re-
sources provided through local public-private
partnerships. General surgeons at two of
the country’s largest health facilities are now
aware of how to perform breast-conserving sur-
gery, including lumpectomy and axillary SLN
mapping/dissection for early-stage disease.
Two general surgeons are undergoing 6months
of additional hands-on training under the tute-
lage of breast cancer surgeons in South Africa,
through a south-south educational collabora-
tion sponsored by the Susan G. Komen Foun-
dation and the Zambian Ministry of Health. A
third has been accepted into a formal surgical
oncology fellowship in India. Active participa-
tion in local clinics and surgical theaters by the
US oncology experts provided themwith unique
insights into the challenges of breast cancer
control in Zambia and will serve to shape future
surgical training collaborative efforts.
Future initiativeswill concentrateon theexpansion
of breast cancer early detection and surgical treat-
ment services throughout the country. This will
require increased training of nurses, radiogra-
phers, and surgeons as well as an effective system
to monitor quality, access timely and accurate
pathology services, and obtain patient follow-up
information. As awareness is increasedandCBE is
more widely implemented, early-stage presenta-
tion will become more prevalent and the demand
for breast conservation surgical skills, as well as
those for breast reconstruction, will increase.
In conclusion, system-level barriers to early de-
tection and treatment of cancer continue toplague
LMICs. We leveraged an existing cervical cancer
prevention platform to introduce breast cancer
education, detection, and surgical treatment ser-
vices by investing in the development of local
clinical expertise. Overall, this initiative has in-
creased breast care capacity in Zambia and, if
properly scaled, can serve to improve the diagno-
sis and management of early-stage breast cancer
at a national level, which thereby reducing breast
cancer morbidity and mortality.
DOI: https://doi.org/10.1200/JGO.17.00026
Published online on jgo.org on September 8, 2017.
Table 5. Breast Cancer Surgery
Procedure Performed (N = 24) No. of Procedures
Breast lumpectomy 10
Sentinel lymph node mapping 6
Sentinel lymph node dissection 8
Table 6. Project Impact
Impact Type
Clinical
Clinical breast examination available at four cervical cancer prevention clinics
Diagnostic
Ultrasound evaluation and ultrasound-guided core needle biopsy of palpable breast
masses available at two breast cancer diagnostic clinics
Surgical
Capacity increased for axillary sentinel lymph node mapping/sampling and breast
lumpectomy at themajor academicmedical training center and one of ten provincial
medical facilities
Other
New partnerships between US breast oncology experts and Zambian clinicians
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